000			02119 a2200517 4500
005			20250514022437.0
264		0	_c20020212
008			200202s 0 0 eng d
022			_a0022-1767
024	7		_a10.4049/jimmunol.168.3.1338 _2doi
040			_aNLM _beng _cNLM
100	1		_aHoffmann, Thomas K
245	0	0	_aThe ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cFeb 2002
300			_a1338-47 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAmino Acid Substitution _xgenetics
650	0	4	_aAntigen Presentation _xgenetics
650	0	4	_aCarcinoma, Squamous Cell _xgenetics
650	0	4	_aCells, Cultured
650	0	4	_aCytotoxicity Tests, Immunologic
650	0	4	_aEpitopes, T-Lymphocyte _xgenetics
650	0	4	_aGene Rearrangement, beta-Chain T-Cell Antigen Receptor
650	0	4	_aHLA-A2 Antigen _xmetabolism
650	0	4	_aHumans
650	0	4	_aImmune Tolerance _xgenetics
650	0	4	_aLeukocytes, Mononuclear _ximmunology
650	0	4	_aLymphocyte Activation _xgenetics
650	0	4	_aMouth Neoplasms _xgenetics
650	0	4	_aPeptide Fragments _xgenetics
650	0	4	_aProtein Binding _xgenetics
650	0	4	_aReceptors, Antigen, T-Cell, alpha-beta _xbiosynthesis
650	0	4	_aT-Lymphocyte Subsets _ximmunology
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
650	0	4	_aTumor Cells, Cultured
650	0	4	_aTumor Suppressor Protein p53 _xgenetics
700	1		_aLoftus, Douglas J
700	1		_aNakano, Koji
700	1		_aMaeurer, Markus J
700	1		_aChikamatsu, Kazuaki
700	1		_aAppella, Ettore
700	1		_aWhiteside, Theresa L
700	1		_aDeLeo, Albert B
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 168 _gno. 3 _gp. 1338-47
856	4	0	_uhttps://doi.org/10.4049/jimmunol.168.3.1338 _zAvailable from publisher's website
999			_c11712567 _d11712567